Antiangiogenc therapy for dogs with splenic hemangiosarcoma
21 May 2009
No Comment
Status: Closed 4/01/03
Eligibility:
Eligibility:
* Splenic hemangiosarcoma - successfully removed by splenectomy within 14 days of study entry
* No gross metastatic disease
* No concurrent chemotherapy
Trial Support: Study drug and follow up costs are supported by trial sponsor. Details on participating veterinary centers will be made available shortly.
Pet owners seeking novel treatment options for animals with serious health conditions find an Animal Clinical Investigation network veterinarian participating in a clinical trial.
Animal Clinical Investigation network veterinarian and pet owner work together to determine whether the pet is eligible for the trial. Eligible pets begin treatment at an ACI network hospital.
Information from the trial is used to help develop new drugs and treatments, providing a source of hope for people whose pets face serious illnesses.